Foundation Medicine, Inc. recalls Sequencing Agent SEQ0067
FDA Class II
FDA classified this recall as Class II: the product may cause health problems that are temporary or can be treated; the chance of serious harm is remote.
- Hazard
- Possible increase in phasing, potentially resulting in false-positive BARD1 splice site indel artifact variants
- Products
-
- Sequencing Agent SEQ0067
- Company
- Foundation Medicine, Inc.
- Where it was sold
-
US Nationwide distribution in the states of Massachusetts and North Carolina.
States: Massachusetts, North Carolina
- Units affected
- 163 units
- About this recall
- Sequencing Agent SEQ0067, component of FoundationOne CDx (F1CDx)